Drugs.com Newsletter Archive

Our popular newsletter containing a regular roundup of medication news, alerts and new drug approvals.

Archive

Monthly News Roundup Vol 176, April 2019
Monthly News Roundup Vol 175, March 2019
Monthly News Roundup Vol 174, February 2019
Monthly News Roundup Vol 173, January 2019
Monthly News Roundup Vol 172, December 2018
Monthly News Roundup Vol 171, November 2018
Monthly News Roundup Vol 170, October 2018
Monthly News Roundup Vol 169, September 2018
Monthly News Roundup Vol 168, August 2018
Monthly News Roundup Vol 167, July 2018
Monthly News Roundup Vol 166, June 2018

Recently Approved

Nayzilam Nayzilam (midazolam) is a nasally administered benzodiazepine indicated for the...
Ruzurgi Ruzurgi (amifampridine) is a potassium-channel blocker indicated for the...
Vyndaqel Vyndaqel (tafamidis meglumine) is a transthyretin stabilizer indicated for the...
Qternmet XR Qternmet XR (dapagliflozin, metformin hydrochloride and saxagliptin) is a...

More approvals

Subscribe to our newsletters

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include IBM Watson Micromedex (updated 1 May 2019), Cerner Multum™ (updated 2 May 2019), Wolters Kluwer™ (updated 1 May 2019) and others.

Drugs.com Newsletter Archive

Archive

Support

About

Terms & Privacy

Drugs.com Newsletter Archive

Archive

Drugs.com Mobile Apps

Support

About

Terms & Privacy